Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn’s Disease Patients
暂无分享,去创建一个
[1] S. Vermeire,et al. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] Jie-shou Li,et al. Diagnostic delay in Crohn's disease is associated with increased rate of abdominal surgery: A retrospective study in Chinese patients. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[3] M. Vos,et al. 924 Long-Term Outcomes of Top-Down Versus Step-up Treatment in Newly Diagnosed Crohn's Disease: Final Data , 2015 .
[4] S. Vermeire,et al. Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative. , 2014, Journal of Crohn's & colitis.
[5] G. Fiorino,et al. Catching the therapeutic window of opportunity in early Crohn's disease. , 2014, Current drug targets.
[6] C. Poupardin,et al. Diagnostic delay in a French cohort of Crohn's disease patients. , 2014, Journal of Crohn's & colitis.
[7] G. Rogler,et al. Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate , 2013, The American Journal of Gastroenterology.
[8] J. Mary,et al. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. , 2013, Gastroenterology.
[9] S. Schreiber,et al. Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process , 2012, The American Journal of Gastroenterology.
[10] G. Rogler,et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[11] V. Chouraki,et al. The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10‐ to 19‐year‐old age bracket (1988–2007) , 2011, Alimentary pharmacology & therapeutics.
[12] A. Zinsmeister,et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. , 2010, Gastroenterology.
[13] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[14] C. O'Morain,et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. , 2010, Journal of Crohn's & colitis.
[15] P. Dagnelie,et al. Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms. , 2009, Journal of Crohn's & colitis.
[16] C. Poupardin,et al. Socioeconomic deprivation does not influence the severity of Crohn's disease: Results of a prospective multicenter study , 2009, Inflammatory bowel diseases.
[17] T. Piche. Impact de la chirurgie gynécologique sur le développement du syndrome de l’intestin irritable et des douleurs abdominales , 2008 .
[18] P. Seksik,et al. Predictors of Crohn's disease. , 2006, Gastroenterology.
[19] J. Belaiche,et al. Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype , 2003, Gut.
[20] F. Carbonnel,et al. Long-Term Evolution of Disease Behavior of Crohn's Disease , 2002, Inflammatory bowel diseases.